• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mind Medicine Mindmed Inc (NQ: MNMD )

    8.380 +0.190 (+2.32%)
    Streaming Delayed Price Updated: 3:15 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mind Medicine Mindmed Inc

    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 13
    ...
    31 32 Next >
    Cybin, Mind Medicine Among Top Psychedelic Movers Of Today
    Via Benzinga
    Psychedelic Stock Gainers And Losers From April 18, 2023
    Via Benzinga
    MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting
    From MindMed
    Via Business Wire
    Psychedelic Stock Gainers And Losers From April 17, 2023
    Via Benzinga
    Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
    Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules 
    Via Benzinga
    80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
    Psychedelics biopharma company Mind Medicine Inc.’s (NASDAQ: MNMD) shared positive topline data from an advanced clinical trial evaluating its lysergide (aka LSD) for the treatment of Major Depressive... 
    Via Benzinga
    ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today
    Via Benzinga
    Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday. 
    Via Benzinga
    Why Is Ocugen (OCGN) Stock Moving Today?
    Ocugen (OCGN) stock is on the move Friday after the company revealed preliminary results from an ongoing clinical trial. 
    Via InvestorPlace
    US Stocks Mixed; Retail Sales Drop 1% In March
    U.S. stocks traded mixed this morning, following the release of economic reports. Following the market opening Friday, the Dow traded up 0.08% to 34,055.40 while the NASDAQ fell 0.10% to 12,153.84. The... 
    Via Benzinga
    Why Is Mind Medicine (MNMD) Stock Up 26% Today?
    Mind Medicine (MNMD) stock is on the rise Friday after releasing positive results from a Phase 2 clinical trial of lysergide (LSD). 
    Via InvestorPlace
    MindMed Reveals Topline Data From Mid-Stage Depression Study Evaluating Lysergide
    Mind Medicine Inc's (NASDAQ: MNMD) collaborators have released topline data from a double-blind, investigator-initiated trial evaluating lysergide major depressive disorder (MDD). 
    Via Benzinga
    MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
    From MindMed
    Via Business Wire
    Psychedelic Stock Gainers And Losers From April 13, 2023
    Via Benzinga
    EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics
    The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space. 
    Via Benzinga
    MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary
    From MindMed
    Via Business Wire
    Psychedelic Stock Gainers And Losers From April 12, 2023
    Via Benzinga
    Psychedelic Stock Gainers And Losers From April 11, 2023
    Via Benzinga
    Psychedelic Stock Gainers And Losers From April 10, 2023
    Via Benzinga
    Psychedelic Stock Gainers And Losers From April 7, 2023
    Via Benzinga
    Psychedelic Stock Gainers And Losers From April 6, 2023
    Via Benzinga
    Compass Pathways, GH Research Among Top Psychedelic Movers Of Today
    Via Benzinga
    Psychedelic Stock Gainers And Losers From April 4, 2023
    Via Benzinga
    "Multi-Bagger" Portfolio Down 13% In March; Still Up Almost 6% YTD
    The 
    Via Talk Markets
    Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
    Via Benzinga
    Largest Psychedelic Stocks -3.4% In March
    The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts. 
    Via Talk Markets
    Psychedelic Stock Gainers And Losers From March 31, 2023
    Via Benzinga
    Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
    Via Benzinga
    Psychedelic Stock Gainers And Losers From March 29, 2023
    Via Benzinga
    Psychedelic Stock Gainers And Losers From March 28, 2023
    Via Benzinga
    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 13
    ...
    31 32 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.